|
|
|
|
|
|
|
|
|
|
Note: while this is not specific to ovarian cancer knowing the side effects which patients experienced may be helpful
Tuesday, January 19, 2010
abstract: Safety and efficacy results of the advanced renal cell carcinoma Sorafenib expanded access program in North America
Note: while this is not specific to ovarian cancer knowing the side effects which patients experienced may be helpful
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.